News
This summer, the Grammy Award-winning hip-hop icon Nas will become the first nationally renowned rap artist to perform with the Baltimore Symphony Orchestra in the organization’s 109-year history.
NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to ...
Avadel has initiated four patent infringement lawsuits against Jazz Pharmaceuticals since the beginning of 2025, alleging certain uses of Jazz’s Xywav product, according to its corresponding labeling, ...
TRE-515, a small molecule inhibitor of deoxycytidine kinase, is being developed for autoimmune diseases and in clinical trials for tumors.
Proprio’s Paradigm AI guidance platform displays real-time progress during surgery, replacing X-ray and CT scans.
Proprio announced today that it received its second FDA 510(k) clearance for its Paradigm AI guidance platform for surgery.
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step ...
Using approved MS drug Copaxone during pregnancy or breastfeeding does not appear to raise the risk of problems for the child ...
4d
Zacks Investment Research on MSNAMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease IndicationAmgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The ...
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results